Sena Therapeutics is developing a pipeline focused on precision Kisspeptin therapies for endocrine disorders. By targeting the Kisspeptin signaling pathway, the company aims to restore hormonal balance in conditions such as polycystic ovary syndrome (PCOS) and hypothalamic amenorrhea. Their approach leverages the pivotal role of Kisspeptin in regulating reproductive hormones, offering a novel avenue for treating endocrine dysfunctions.
Company Details
- Employees
- 1
- Address
- 299 Revolution Drive, Somerville,massachusetts 02145,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- HQ
- Somerville, Massachusetts
Sena Therapeutics Questions
Sena Therapeutics's LinkedIn profile is https://www.linkedin.com/company/sena-therapeutics
Sena Therapeutics has
1 employees.
View email and phone details for 1
employees at Sena Therapeutics.
Sena Therapeutics's industry is
Biotechnology Research
Sena Therapeutics's top competitors are
Geminii Health,
Medical Decision Modeling Inc.,
Liviwell,
The Institute For Genomic Research,
Claire,
Global Strategies,
Avamed Workforce,
Biotech Ceo Sisterhood,
M3info.ai,
Familial Dysautonomia Foundation.
Sena Therapeutics's categories are Biotechnology Research
